Thymidylate Synthase
Read More about this categoryShow Less
Thymidylate synthase (TS) is an enzyme catalyzing the sole de novo pathway for the biosynthesis of deoxythymidine monophosphate (dTMP) in which deoxyuridine monophosphate (dUMP) is reductively methylated by 5,10-methylenetetrahydrofolate (CH2H4folate) with the generation of dTMP and dihydrofolate (H2folate). TS has been found in a wide range of sources, including bacteria, bacteriophage, yeast, viruses and vertebrates, where it is usually a dimer consisting of identical subunits (30 to 35 kDa each). However, protozoal TS is a bifunctional protein with dihydrofolate reductase (DHFR) on the same polypeptide chain, where TS and DHFR domains are located on the carboxy terminus and amino terminus respectively.
Products Related to Thymidylate Synthase(10)
- GC11099DoxifluridineCAS: 3094-09-5Purity: >99.50%
oral prodrug of the antineoplastic agent 5-fluorouracil (5-FU)
- GC13803TrifluridineCAS: 70-00-8Purity: >99.50%
Triflurdine (Viroptic) (Trifluorothymidine; 5-Trifluorothymidine; TFT) is an irreversible thymidylate synthase inhibitor, and thereby suppresses DNA synthesis. Triflurdine (Viroptic) is an antiviral drug for herpes simplex virus (HSV) infection. Trifluorothymidine also has anti-orthopoxvirus activity.
- GC11610PemetrexedCAS: 150399-23-8Purity: >99.00%
Pemetrexed (also known as pemetrexed disodium) is a novel antifolate antimetabolite targeting multiple enzymes involved in both pyrimidine and purine synthesis.
- GC14681Nolatrexed (AG-337)CAS: 152946-68-4Purity: >98.50%
Nolatrexed (AG-337) (AG 337) is a non-competitive lipophilic inhibitor of thymidylate synthase, interacts at the folate cofactor binding site of the enzyme, with a Ki of 11 nM for human thymidylate synthase. Nolatrexed (AG-337) (AG 337) induces cell cycle arrest in S phase of cancer cells. Anti-cancer activity.
- GC19348TAS-102CAS: 733030-01-8Purity: >98.00%
TAS-102 (TAS-102) is a potent and orally active nucleoside antitumor agent. The composition of TAS-102 (TAS-102) is a 1:0.5 mixture (on a molar basis) of alpha,alpha,alpha-tri-fluorothymidine (FTD) and thymidine phosphorylase inhibitor (TPI). TAS-102 (TAS-102) shows the antitumor activity mainly via the inhibition of thymidylate synthase (TS) and incorporation into DNA.
- GC62645Fosifloxuridine nafalbenamideCAS: 1332837-31-6Purity: >98.00%
Fosifloxuridine nafalbenamide (NUC-3373), a pyrimidine nucleotide analogue, is a Thymidylate synthase inhibitor. Fosifloxuridine nafalbenamide has anticancer activity. Fosifloxuridine nafalbenamide has the potential to evoke a host immune response and enhance immunotherapy.
- GC6472610-Formyl-5,8-dideazafolic acidCAS: 61038-31-1Purity: >96.00%
10-Formyl-5,8-dideazafolic acid is a thymidylate synthase inhibitor.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC11099 | Doxifluridine | 3094-09-5 | >99.50% | |
oral prodrug of the antineoplastic agent 5-fluorouracil (5-FU) | ||||
| GC13803 | Trifluridine | 70-00-8 | >99.50% | |
Triflurdine (Viroptic) (Trifluorothymidine; 5-Trifluorothymidine; TFT) is an irreversible thymidylate synthase inhibitor, and thereby suppresses DNA synthesis. Triflurdine (Viroptic) is an antiviral drug for herpes simplex virus (HSV) infection. Trifluorothymidine also has anti-orthopoxvirus activity. | ||||
| GC11610 | Pemetrexed | 150399-23-8 | >99.00% | |
Pemetrexed (also known as pemetrexed disodium) is a novel antifolate antimetabolite targeting multiple enzymes involved in both pyrimidine and purine synthesis. | ||||
| GC14681 | Nolatrexed (AG-337) | 152946-68-4 | >98.50% | |
Nolatrexed (AG-337) (AG 337) is a non-competitive lipophilic inhibitor of thymidylate synthase, interacts at the folate cofactor binding site of the enzyme, with a Ki of 11 nM for human thymidylate synthase. Nolatrexed (AG-337) (AG 337) induces cell cycle arrest in S phase of cancer cells. Anti-cancer activity. | ||||
| GC17694 | Pemetrexed disodium hemipenta hydrate | 357166-30-4 | >99.00% | |
| GC17750 | Raltitrexed | 112887-68-0 | >98.00% | |
Thymidylate synthase inhibitor | ||||
| GC19348 | TAS-102 | 733030-01-8 | >98.00% | |
TAS-102 (TAS-102) is a potent and orally active nucleoside antitumor agent. The composition of TAS-102 (TAS-102) is a 1:0.5 mixture (on a molar basis) of alpha,alpha,alpha-tri-fluorothymidine (FTD) and thymidine phosphorylase inhibitor (TPI). TAS-102 (TAS-102) shows the antitumor activity mainly via the inhibition of thymidylate synthase (TS) and incorporation into DNA. | ||||
| GC37798 | Tipiracil | 183204-74-2 | >98% | |
Tipiracil is a competitive inhibitor of thymidine phosphorylase (TPase), with an apparent Ki value of 17nM against recombinant human TPase. | ||||
| GC62645 | Fosifloxuridine nafalbenamide | 1332837-31-6 | >98.00% | |
Fosifloxuridine nafalbenamide (NUC-3373), a pyrimidine nucleotide analogue, is a Thymidylate synthase inhibitor. Fosifloxuridine nafalbenamide has anticancer activity. Fosifloxuridine nafalbenamide has the potential to evoke a host immune response and enhance immunotherapy. | ||||
| GC64726 | 10-Formyl-5,8-dideazafolic acid | 61038-31-1 | >96.00% | |
10-Formyl-5,8-dideazafolic acid is a thymidylate synthase inhibitor. | ||||
